Topics Topics

Daugavpils vaccines all booked after offering choice of manufacturer

Daugavpils Regional Hospital allowed priority groups to choose one of the two vaccines at the hospital's disposal  – AstraZeneca or Pfizer, and the doses are 'all booked' at the hospital, Rus.LSM.lv reported April 14.

“I'm satisfied. People have booked 300 doses in two days,” Grigorijs Semjonovs, the head of the hospital, told the portal Rus.LSM.lv.

“The main thing we wanted is to increase population activity. And we have succeeded. Two days ago, I had 250 doses of “Vaxzevria” (the vaccine produced by AstraZeneca) and 54 doses of Pfizer/BioNTech. And 10 to 15 people applied per day, no more. It was clear that vaccines could be lost, and that is not acceptable,” the hospital manager said.

“And I offered a choice, I risked it. The laws do not prohibit choice! We wanted to see if there would be a positive effect. And here it is, people are still calling, (..) I believe I did the right thing,” Semjonovs said.

In the future, the hospital will change its approach – people will have the opportunity to express their views on what kind of vaccine they would like, “at least we will know what's in their heads, which is not bad, because opinions can be different”, Semjonovs said.

"At first, many didn't want Pfizer, waited for AstraZeneca, later after news of the rare cases of thrombosis following AstraZeneca's vaccines changed the situation, and Pfizer became more popular, and people have started mass refusal of AstraZeneca. What's going to be next, we don't know. But we will try to take people's wishes into account when ordering vaccines so that they do not have to be discarded,” Semjonovs said.

Seen a mistake?

Select text and press Ctrl+Enter to send a suggested correction to the editor

Select text and press Report a mistake to send a suggested correction to the editor

Related articles
Health
Society

Please be aware that the LSM portal uses cookies. By continuing to use this site, you agree that we may store and use cookies on your device. Find out more

Accept and continue